Ayyappa Chaturvedula
Senior Director at Pumas-AI, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Jeff Garwin
I found Ayyappa to be highly competent in biopharmaceutic formulation and in unraveling PK/PD data. I worked with Ayyappa on three different projects at GSK Consumer Healthcare, each of which posed different and significant challenges. Ayyappa brings a passion for understanding the biology and biochemistry that underlies the observed drug effects. Ayyappa was particularly thorough in researching the patent and scientific literature, with the result that his development work was maximally productive. Ayyappa also introduced new ways of thinking about early phase development work to the Venture Group. His contributions were particularly valuable to the clinical development team.
Jeff Garwin
I found Ayyappa to be highly competent in biopharmaceutic formulation and in unraveling PK/PD data. I worked with Ayyappa on three different projects at GSK Consumer Healthcare, each of which posed different and significant challenges. Ayyappa brings a passion for understanding the biology and biochemistry that underlies the observed drug effects. Ayyappa was particularly thorough in researching the patent and scientific literature, with the result that his development work was maximally productive. Ayyappa also introduced new ways of thinking about early phase development work to the Venture Group. His contributions were particularly valuable to the clinical development team.
Jeff Garwin
I found Ayyappa to be highly competent in biopharmaceutic formulation and in unraveling PK/PD data. I worked with Ayyappa on three different projects at GSK Consumer Healthcare, each of which posed different and significant challenges. Ayyappa brings a passion for understanding the biology and biochemistry that underlies the observed drug effects. Ayyappa was particularly thorough in researching the patent and scientific literature, with the result that his development work was maximally productive. Ayyappa also introduced new ways of thinking about early phase development work to the Venture Group. His contributions were particularly valuable to the clinical development team.
Jeff Garwin
I found Ayyappa to be highly competent in biopharmaceutic formulation and in unraveling PK/PD data. I worked with Ayyappa on three different projects at GSK Consumer Healthcare, each of which posed different and significant challenges. Ayyappa brings a passion for understanding the biology and biochemistry that underlies the observed drug effects. Ayyappa was particularly thorough in researching the patent and scientific literature, with the result that his development work was maximally productive. Ayyappa also introduced new ways of thinking about early phase development work to the Venture Group. His contributions were particularly valuable to the clinical development team.
Credentials
-
Achieve High Performance Program Graduate
The Achieve InstituteNov, 2022- Oct, 2024
Experience
-
-
Senior Director
-
Jan 2022 - Present
-
-
-
University of North Texas Health Science Center School of Public Health
-
United States
-
Hospitals and Health Care
-
1 - 100 Employee
-
Associate Professor
-
Jun 2021 - Present
-
-
-
Arcus Biosciences
-
United States
-
Biotechnology
-
300 - 400 Employee
-
Director, Clinical pharmacology
-
Jun 2021 - Jan 2022
-
-
-
UNT Health Science Center
-
United States
-
Higher Education
-
700 & Above Employee
-
Associate Professor
-
Sep 2015 - May 2021
-
-
-
GVK Biosciences
-
India
-
Consumer Services
-
1 - 100 Employee
-
General Manager
-
Jul 2014 - Aug 2015
Developing and managing pharmacometrics group, pharmacometrics resources and conducting pharmacometrics analysis Developing and managing pharmacometrics group, pharmacometrics resources and conducting pharmacometrics analysis
-
-
-
Mercer University
-
United States
-
Higher Education
-
100 - 200 Employee
-
Director, Center for Pharmacometrics
-
Jan 2012 - Jun 2014
Building the strategy, conducting pharmacometric projects and teaching,
-
-
Assistant Professor
-
Jun 2011 - Jun 2014
Quantitative Clinical Pharmacology, Biopharmaceutics, Drug delivery
-
-
-
GlaxoSmithKline Consumer Healthcare
-
United States
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Sr. Development Scientist- Venture Group
-
Jul 2008 - Jun 2011
Strategic Growth Initiatives, new product research and development Strategic Growth Initiatives, new product research and development
-
-
-
-
Visiting Scientist
-
Mar 2009 - Mar 2011
Conducts non-commercial research in the department of Biopharmaceutical Sciences in George Town Campus of UCSF. The research activities include population PK-PD modeling of clinical data in the anti-infectives disease area. Conducts non-commercial research in the department of Biopharmaceutical Sciences in George Town Campus of UCSF. The research activities include population PK-PD modeling of clinical data in the anti-infectives disease area.
-
-
-
Schering-Plough Research Institute
-
United States
-
Pharmaceutical Manufacturing
-
400 - 500 Employee
-
Senior Scientist
-
Mar 2007 - Jul 2008
Clinical Pharmacokinetics Clinical Pharmacokinetics
-
-
-
-
Adjunt Faculty
-
Mar 2006 - Mar 2008
Taught Pharmacokinetics course to graduate students Taught Pharmacokinetics course to graduate students
-
-
-
GlaxoSmithKline
-
United States
-
Investment Management
-
Sr. Scientist, New Product Development
-
Mar 2005 - Mar 2007
-
-
Education
-
2001 - 2005
Mercer University
PhD, Pharmaceutical Sciences -
1996 - 2000
Kakatiya University
B.S. in Pharmacy, Pharmaceutical Sciences
Community
